Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 106, Issue 2, 2010, Pages 261-267

  Olivotto, Iacopo ^a   Maron, Barry J ^b   Appelbaum, Evan ^c,d   Harrigan, Caitlin J ^d   Salton, Carol ^c,d   Gibson, C Michael ^c,d   Udelson, James E ^e   O'Donnell, Christopher ^f   Lesser, John R ^b   Manning, Warren J ^c,d   Maron, Martin S ^e  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Heart Institute Foundation   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION; VENTRICULAR REMODELING;

EID: 77955684941     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.03.020     Document Type: Article

References (30)

1. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
2. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer III, P. Spirito, F.J. ten Cate, and E.D. Wigle Task Force on Clinical Expert Consensus Documents American College of Cardiology; Committee for Practice Guidelines; European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice guidelines J Am Coll Cardiol 42 2003 1687 1713
3. K.M. Harris, P. Spirito, M.S. Maron, A.G. Zenovich, F. Formisano, J.R. Lesser, S. Mackey-Bojack, W.J. Manning, J.E. Udelson, and B.J. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225
4. E. Biagini, F. Coccolo, M. Ferlito, E. Perugini, G. Rocchi, L. Bacchi-Reggiani, C. Lofiego, G. Boriani, D. Prandstraller, F.M. Picchio, A. Branzi, and C. Rapezzi Dilated-hypokinetic evolution of hypertrophic cardiomyopathy J Am Coll Cardiol 46 2005 1543 1550
5. R. Thaman, J.R. Gimeno, R.T. Murphy, T. Kubo, B. Sachdev, J. Mogensen, P.M. Elliott, and W.J. McKenna Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy Heart 91 2005 920 925
6. P. Spirito, B.J. Maron, R.O. Bonow, and S.E. Epstein Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy Am J Cardiol 60 1987 123 129
7. I. Olivotto, I. Cecchi, R. Gistri, R. Lorenzoni, G. Chiriatti, F. Girolami, F. Torricelli, and P.G. Camici Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy J Am Coll Cardiol 47 2006 1043 1048
8. C. Rickers, N.M. Wilke, M. Jerosch-Herold, S.A. Casey, P. Panse, N. Panse, J. Weil, A.G. Zenovich, and B.J. Maron Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 2005 855 861
9. F. Grothues, G.C. Smith, J.C. Moon, N.G. Bellenger, P. Collins, H.U. Klein, and D.J. Pennell Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure of left ventricular hypertrophy Am J Cardiol 90 2002 29 34
10. I. Olivotto, M.S. Maron, C. Autore, J.R. Lesser, L. Rega, G. Casolo, M. De Santis, G. Quarta, S. Nistri, F. Cecchi, C.J. Salton, J.E. Udelson, W.J. Manning, and B.J. Maron Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 52 2008 559 566
11. J.C.C. Moon, E. Reed, M.N. Sheppard, A.G. Elkington, S.Y. Ho, M. Burke, M. Petrou, and D.J. Pennell The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264
12. M.S. Maron, E. Appelbaum, C.J. Harrigan, J. Buros, C.M. Gibson, C. Hanna, J.R. Lesser, J.E. Udelson, W.J. Manning, and B.J. Maron Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
13. L. Choudhury, H. Mahrholdt, A. Wagner, K.M. Choi, M.D. Elliott, F.J. Klocke, R.O. Bonow, R.M. Judd, and R.J. Kim Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156 2164
14. R.J. Kim, E. Wu, A. Rafael, E.L. Chen, M.A. Parker, O. Simonetti, F.J. Klocke, R.O. Bonow, and R.M. Judd The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
15. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, and D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
16. R.J. Kim, and R.M. Judd Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol 41 2003 1568 1572
17. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, and W.J. Stewart Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
18. C.J. Salton, M.L. Chuang, C.J. O'Donnell, M.J. Kupka, M.G. Larson, K.V. Kissinger, R.R. Edelman, D. Levy, and W.J. Manning Gender differences and normal left ventricular anatomy in an adult population free of hypertension: a cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort J Am Coll Cardiol 39 2002 1055 1060
19. S. Nistri, I. Olivotto, S. Betocchi, M.A. Losi, G. Valsecchi, B. Pinamonti, M.R. Conte, F. Casazza, M. Galderisi, B.J. Maron, and F. Cecchi Participating Centers Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy) Am J Cardiol 98 2006 960 965
20. M.S. Maron, I. Olivotto, A.G. Zenovich, M.S. Link, N.G. Pandian, J.T. Kuvin, S. Nistri, F. Cecchi, J.E. Udelson, and B.J. Maron Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2006 2232 2239
21. Harrigan CJ, Maron MS, Maron BJ, Peters DC, Gibson CM, Manning WJ, Appelbaum E. Accuracy and reproducibility of quantifying myocardial fibrosis in hypertrophic cardiomyopathy using delayed enhancement cardiovascular magnetic resonance techniques. Radiology. In press.
22. B.J. Maron, P. Spirito, Y. Wesley, and J. Arce Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy N Engl J Med 315 1986 610 614
23. B. Sotgia, R. Sciagr, I. Olivotto, G. Casolo, L. Rega, I. Betti, A. Pupi, P.G. Camici, and F. Cecchi Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy J Nucl Med 49 2008 1090 1096
24. M.S. Maron, I. Olivotto, B.J. Maron, S.K. Prasad, F. Cecchi, J.E. Udelson, and P.G. Camici The case for myocardial ischemia in hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 866 875
25. R.O. Cannon III, W.H. Schenke, B.J. Maron, C.M. Tracy, M.B. Leon, J.E. Brush Jr, D.R. Rosing, and S.E. Epstein Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy J Am Coll Cardiol 10 1987 53 62
26. H. Ashrafian, C. Redwood, E. Blair, and H. Watkins Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion Trends Genet 19 2003 263 268
27. A. Belus, N. Piroddi, B. Scellini, C. Tesi, G.D. Amati, F. Girolami, M. Yacoub, F. Cecchi, I. Olivotto, and C. Poggesi The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils J Physiol 586 2008 3639 3644
28. F. Girolami, C.Y. Ho, C. Semsarian, M. Baldi, M.L. Will, K. Baldini, F. Torricelli, L. Yeates, L. Cecchi, M.J. Ackerman, and I. Olivotto Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations J Am Coll Cardiol 55 2010 1444 1453
29. R. Rubinshtein, J.F. Glockner, S.R. Ommen, P.A. Araoz, M.J. Ackerman, P. Sorajja, J.M. Bos, A.J. Tajik, U.S. Valeti, R.A. Nishimura, and B.J. Gersh Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
30. A.S. Adabag, B.J. Maron, E. Appelbaum, C.J. Harrigan, J.L. Buros, C.M. Gibson, J.R. Lesser, C.A. Hanna, J.E. Udelson, W.J. Manning, and M.S. Maron Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374